No, although the patient and caregiver consent, the patient has no known mutation and complete clinical response

No, although the patient and caregiver consent, the patient has no known mutation and complete clinical response

Start complement inhibition (eculizumab/ravulizumab)

Map: TMA (792)
Node: 16365
Score:

OpenLabyrinth is an open source educational pathway system

Review your pathway

No, although the patient and caregiver consent, the patient has no known mutation and complete clinical response

Reminder

FINISH

Time is up